456 related articles for article (PubMed ID: 30392013)
1. Antimicrobial proteins: intestinal guards to protect against liver disease.
Hendrikx T; Schnabl B
J Gastroenterol; 2019 Mar; 54(3):209-217. PubMed ID: 30392013
[TBL] [Abstract][Full Text] [Related]
2. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
4. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Brandl K; Schnabl B
Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
[TBL] [Abstract][Full Text] [Related]
6. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
7. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota in liver disease.
Haque TR; Barritt AS
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
[TBL] [Abstract][Full Text] [Related]
9. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future.
Lang S; Schnabl B
Cell Host Microbe; 2020 Aug; 28(2):233-244. PubMed ID: 32791115
[TBL] [Abstract][Full Text] [Related]
10. The role of gut microbiota in intestinal and liver diseases.
Hrncir T; Hrncirova L; Kverka M; Tlaskalova-Hogenova H
Lab Anim; 2019 Jun; 53(3):271-280. PubMed ID: 30580671
[TBL] [Abstract][Full Text] [Related]
11. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
Betrapally NS; Gillevet PM; Bajaj JS
Gastroenterology; 2016 Jun; 150(8):1745-1755.e3. PubMed ID: 26948887
[TBL] [Abstract][Full Text] [Related]
12. The role of the gut microbiota in the pathology and prevention of liver disease.
Altamirano-Barrera A; Uribe M; Chávez-Tapia NC; Nuño-Lámbarri N
J Nutr Biochem; 2018 Oct; 60():1-8. PubMed ID: 29653359
[TBL] [Abstract][Full Text] [Related]
13. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
[TBL] [Abstract][Full Text] [Related]
14. Interactions between the intestinal microbiome and liver diseases.
Schnabl B; Brenner DA
Gastroenterology; 2014 May; 146(6):1513-24. PubMed ID: 24440671
[TBL] [Abstract][Full Text] [Related]
15. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of microbiome in patients with decompensated cirrhosis.
Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
[TBL] [Abstract][Full Text] [Related]
17. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and non-alcoholic fatty liver disease.
Gkolfakis P; Dimitriadis G; Triantafyllou K
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):572-81. PubMed ID: 26663004
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
20. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease.
Stärkel P; Leclercq S; de Timary P; Schnabl B
Clin Sci (Lond); 2018 Jan; 132(2):199-212. PubMed ID: 29352076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
